Fluctuation of gastrointestinal symptoms in the community: A 10-year longitudinal follow-up study

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 8, 2008, Pages 1013-1020

  Ford, A C ^a,d   Forman, D ^b   Bailey, A G ^a   Axon, A T R ^a   Moayyedi, P ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMMUNITY; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE;

ENGLAND; EPIDEMIOLOGIC METHODS; FEMALE; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED;

EID: 52149106904     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03813.x     Document Type: Article

References (24)

1. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995 109 : 671 80.
2. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders. Am J Gastroenterol 2001 96 : 2905 14.
3. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. Br Med J 1989 298 : 30 2.
4. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000 14 : 1589 94.
5. Locke GR III., Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III.,. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112 : 1448 56.
6. Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996 10 : 83 9.
7. Hungin APS, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003 17 : 643 50.
8. Jones R, Lydeard S. Irritable bowel syndrome in the general population. Br Med J 1992 304 : 87 90.
9. Wilson S, Roberts L, Roalfe A, Bridge P, Singh S. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 2004 54 : 495 502.
10. Mearin F, Baro E, Roset M, Badia X, Zarate N, Perez I. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol 2004 99 : 113 21.
11. Weir RD, Backett EM. Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer. Gut 1968 9 : 75 83.
12. Halder SLS, Locke GR III., Schleck CD, Zinsmeister AR, Melton LJ III., Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007 133 : 799 807.
13. Ford AC, Forman D, Bailey AG, Axon ATR, Moayyedi P. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 2007 56 : 321 7.
14. Moayyedi P, Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000 355 : 1665 9.
15. Ford AC, Forman D, Bailey AG, Axon ATR, Moayyedi P. Irritable bowel syndrome: a 10-year natural history of symptoms, and factors that influence consultation behavior. Am J Gastroenterol 2008 103 : 1229 39.
16. Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds dyspepsia questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther 1998 12 : 1257 62.
17. Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In : Wenger NK, Mattson ME, Fruberg CF, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York : Le Jacq Publishing Inc, 1984 : 170 83.
18. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978 277 : 653 4.
19. Fraser A, Delaney BC, Ford AC, Qume M, Moayyedi P. The short-form Leeds dyspepsia questionnaire validation study. Aliment Pharmacol Ther 2007 25 : 477 86.
20. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006 130 : 1466 79.
21. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999 45 (Suppl. II II43 7.
22. Hillila MT, Farkkila MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004 20 : 339 45.
23. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000 95 : 2816 24.
24. Agreus L, Talley NJ, Svardsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort, and bowel habit descriptors. Scand J Gastroenterol 2000 35 : 142 51.